Literature DB >> 1494911

Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.

S Grady1, M J Marks, S Wonnacott, A C Collins.   

Abstract

This study establishes that presynaptic nicotinic receptors modulate dopamine release in the mouse striatum. Nicotinic agonists elicit a dose-dependent increase in the release of [3H]dopamine from synaptosomes prepared from mouse striatum. At low concentrations, this release is Ca2+ dependent, whereas at higher concentrations Ca(2+)-independent, mecamylamine-insensitive release was also observed. The Ca(2+)-dependent nicotine-evoked release was not blocked by alpha-bungarotoxin but was effectively blocked by neuronal bungarotoxin as well as several other nicotinic receptor antagonists. The relationship between potency for stimulation of release for agonists and potency for inhibition of release for antagonists was compared to the affinity of these compounds for the [3H]nicotine binding site. The overall correlation between release and binding potency was not high, but the drugs may be classified into separate groups, each of which has a high correlation with binding. This finding suggests either that more than one nicotinic receptor regulates dopamine release or that not all agonists interact with the same receptor in an identical fashion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494911     DOI: 10.1111/j.1471-4159.1992.tb08322.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  88 in total

1.  Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

Authors:  Michele Zoli; Milena Moretti; Alessio Zanardi; J Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Direct recording of nicotinic responses in presynaptic nerve terminals.

Authors:  J S Coggan; J Paysan; W G Conroy; D K Berg
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning.

Authors:  Thomas J Gould; Michael C Lewis
Journal:  Learn Mem       Date:  2005 Jul-Aug       Impact factor: 2.460

4.  A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine.

Authors:  Joshua T Ayers; Rui Xu; Linda P Dwoskin; Peter A Crooks
Journal:  AAPS J       Date:  2005-10-31       Impact factor: 4.009

5.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

6.  Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice.

Authors:  Deniz Bagdas; Clare M Diester; Jason Riley; Moriah Carper; Yasmin Alkhlaif; Dana AlOmari; Hala Alayoubi; Justin L Poklis; M Imad Damaj
Journal:  Neuropharmacology       Date:  2019-06-18       Impact factor: 5.250

7.  Chronic treatments with cholinoceptor drugs influence spatial learning in rats.

Authors:  F A Abdulla; M R Calaminici; J D Stephenson; J D Sinden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder.

Authors:  Alexandra S Potter; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

9.  Transport of dopamine at the blood-brain barrier of the guinea pig: inhibition by psychotropic drugs and nicotine.

Authors:  C L Martel; J B Mackic; J D Adams; J G McComb; M H Weiss; B V Zlokovic
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

10.  Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Authors:  Zhenfa Zhang; Guangrong Zheng; Marharyta Pivavarchyk; A Gabriela Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2008-09-26       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.